Koyfin Home > Directory > Health Care > Amphastar Pharma > Price / Earnings (ltm)

Amphastar Pharma Price / Earnings (ltm) Chart (AMPH)

Amphastar Pharma annual/quarterly Price / Earnings (ltm) from 2014 to 2018. The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its consensus EPS estimate of the next twelve months (NTM). The price-earnings ratio is also sometimes known as the price multiple or the earnings multiple.
  • Amphastar Pharma Price / Earnings (ltm) for the quarter ending March 03, 2018 was 208.33 a 68.36% increase of 142.42 year over year
Other Valuation Metrics:
  • Amphastar Pharma Market Cap for the quarter ending March 03, 2018 was $869m a 6.01% increase of 52m year over year
  • Amphastar Pharma Price / Book for the quarter ending March 03, 2018 was 2.59 a 2.71% increase of 0.07 year over year
  • Amphastar Pharma Enterprise Value for the quarter ending March 03, 2018 was $848m a 8.52% increase of 72m year over year
View Chart On Koyfin

Quarterly AMPH Price / Earnings (ltm) Data

03/2018208.33
09/2017233.03
06/201794.14
03/201765.91
12/201640.24
09/201661.51
06/201449.31

Annual AMPH Price / Earnings (ltm) Data

201640.24